Application 021292
- Type
- NDA
- Sponsor
- PROVELL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 002 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 003 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 004 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 005 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 006 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 007 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 008 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 009 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 010 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 011 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 012 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021292-001 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.025MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-002 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.05MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-003 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.075MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-004 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.088MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-005 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.1MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-006 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.112MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-007 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.125MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-008 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.137MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-009 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.15MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-010 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.175MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-011 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.2MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-012 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.3MG | TABLET / ORAL | 2002-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021292-001 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-002 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-003 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-004 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-005 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-006 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-007 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-008 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-009 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-010 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-011 | AB2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-001 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-002 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-003 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-004 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-005 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-006 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-007 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-008 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-009 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-010 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-011 | AB2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-001 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-002 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-003 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-004 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-005 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-006 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-007 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-008 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-009 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-010 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-011 | AB2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-001 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-002 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-003 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-004 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-005 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-006 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-007 | AB2 | 1 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | b4f8dfd0-b15a-4da5-a0d0-ad768e0b7ff8 | 2024-09-01 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 8f83fd60-5aa7-4e7f-a6e9-917e2c1abf27 | 2024-08-21 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | b1b8c5a4-8132-24d2-e053-2995a90a59ec | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Aurobindo Pharma Limited | c760d0cc-2245-4914-8c67-d536c41ac90f | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | cba6bb77-2140-6cba-e053-2995a90aa1b6 | 2024-07-14 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Hikma Pharmaceuticals USA Inc. | 6279390b-ee61-4ef9-ac15-25537ca783c1 | 2024-07-10 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | a2157cf0-5c8f-7e69-e053-2a95a90aa083 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | a215da96-acd9-6b8d-e053-2995a90a7e0d | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | NuCar Pharmaceuticals,Inc. | a2194c58-b755-e6b5-e053-2a95a90a36d4 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 1ac856d1-7067-a71d-e063-6294a90acc7c | 2024-06-13 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 56c633a9-3f64-46bd-b93f-afbff92b5559 | 2024-06-03 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Teva Pharmaceuticals, Inc. | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 2024-06-01 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | DIRECT RX | a5f15022-1166-09fe-e053-2a95a90aa218 | 2024-05-23 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 8849620a-5e8d-4031-884f-9a2817b050f2 | 2024-05-02 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | e1b322a6-9161-45b9-bf77-3c44502d5efd | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e486f83b-6cf0-4e7d-99ed-cfd19c4501e1 | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d35b5250-c26d-4d67-8a33-2f993b13e3e9 | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d6ce9798-7204-41df-9aeb-067000cb0895 | 2024-04-05 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Macleods Pharmaceuticals Limited | b8c20f76-3ee6-4b29-b77f-ed4ad1baaed9 | 2024-03-04 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Synthroid | LEVOTHYROXINE SODIUM | AbbVie Inc. | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 2024-02-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 70915 | SUPPL | 2022-05-03 |
| 70873 | SUPPL | 2022-05-02 |
| 55504 | SUPPL | 2018-09-18 |
| 55503 | SUPPL | 2018-09-18 |
| 55502 | SUPPL | 2018-09-18 |
| 55498 | SUPPL | 2018-09-18 |
| 55497 | SUPPL | 2018-09-18 |
| 55496 | SUPPL | 2018-09-18 |
| 36600 | SUPPL | 2009-04-03 |
| 4947 | SUPPL | 2009-04-01 |
| 21579 | ORIG | 2004-06-29 |
| 15125 | ORIG | 2002-05-31 |
| 4946 | ORIG | 2002-05-31 |